RNA

Engineered mRNA has turned cells into tiny biofactories, producing medications to successfully treat an inflammatory skin condition and two types of cancer, according to a new study. The tech paves the way for therapies in which patients’ bodies make their own drugs.

Glioblastoma is one of the most deadly cancers, with few treatment options available. Now, a small human clinical trial has demonstrated an mRNA vaccine that quickly rallies the immune system to fight off the tumors, with promising results.

Cow’s milk contains nanoparticles that can be used to deliver RNA therapy orally, say researchers. With such drugs currently only administrable by injection, the discovery opens the door to cheaper, more accessible treatments for a range of diseases.

A man that police caught taking 217 doses of COVID vaccine has offered himself up to researchers for a study looking into what happens to the immune system after so many doses. The results offer surprising insight into these new mRNA vaccines.

Our bodies are home to trillions of microbes, including bacteria, viruses, fungi, and a whole host of others. Now, Stanford scientists have discovered an entirely new class of biological entities inside us, which they’ve ominously named “Obelisks.”

Researchers have created a ‘two-headed’ drug that prevents the production of the toxic protein linked to Parkinson’s disease before destroying the RNA machinery that makes it. The drug may be a way of slowing or even stopping the disease’s progression.

Moderna has announced results of a Phase 2b trial of its mRNA treatment for skin cancer. When paired with immunotherapy, the treatment significantly reduced risks of recurrence, metastasis and death, paving the way for trials against other cancers.

Researchers have discovered that mice possess a natural form of gene therapy, a non-coding RNA that can sidestep genetic mutations. They were able to engineer a programmable version that might be used to treat genetic diseases in humans.

Researchers discovered that a modification to the synthetic mRNA used in therapeutics can cause the cell’s machinery to misread its instructions, leading to unintended immune responses. Importantly, they’ve also discovered a solution to the problem.

Researchers have conducted the first human trials of a new drug, lepodisiran, and found that a single injection reduced lipoprotein(a) – a ‘bad’ cholesterol with a genetic basis and no available treatments – to undetectable levels for almost a year.

Researchers investigating the genetics underlying the airway inflammation seen in severe asthma have, for the first time, discovered that proteins that bind to RNA are dysregulated, driving changes in gene expression in cells that line the airways.

Researchers have found that remnants left over after a cell divides contain RNA that, when taken up by other cells, can spread cancer’s genetic blueprint. The finding opens the door to harnessing this mechanism as a way of treating cancer.